File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

TitleCD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
Authors
KeywordsCOVID-19
immunodominant
SARS-CoV-2-specific CD8+
T cells
TCR
Issue Date2021
Citation
Immunity, 2021, v. 54, n. 5, p. 1066-1082.e5 How to Cite?
AbstractTo better understand primary and recall T cell responses during coronavirus disease 2019 (COVID-19), it is important to examine unmanipulated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells. By using peptide-human leukocyte antigen (HLA) tetramers for direct ex vivo analysis, we characterized CD8+ T cells specific for SARS-CoV-2 epitopes in COVID-19 patients and unexposed individuals. Unlike CD8+ T cells directed toward subdominant epitopes (B7/N257, A2/S269, and A24/S1,208) CD8+ T cells specific for the immunodominant B7/N105 epitope were detected at high frequencies in pre-pandemic samples and at increased frequencies during acute COVID-19 and convalescence. SARS-CoV-2-specific CD8+ T cells in pre-pandemic samples from children, adults, and elderly individuals predominantly displayed a naive phenotype, indicating a lack of previous cross-reactive exposures. T cell receptor (TCR) analyses revealed diverse TCRαβ repertoires and promiscuous αβ-TCR pairing within B7/N105+CD8+ T cells. Our study demonstrates high naive precursor frequency and TCRαβ diversity within immunodominant B7/N105-specific CD8+ T cells and provides insight into SARS-CoV-2-specific T cell origins and subsequent responses.
Persistent Identifierhttp://hdl.handle.net/10722/355899
ISSN
2023 Impact Factor: 25.5
2023 SCImago Journal Rankings: 13.578
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorNguyen, Thi H.O.-
dc.contributor.authorRowntree, Louise C.-
dc.contributor.authorPetersen, Jan-
dc.contributor.authorChua, Brendon Y.-
dc.contributor.authorHensen, Luca-
dc.contributor.authorKedzierski, Lukasz-
dc.contributor.authorvan de Sandt, Carolien E.-
dc.contributor.authorChaurasia, Priyanka-
dc.contributor.authorTan, Hyon Xhi-
dc.contributor.authorHabel, Jennifer R.-
dc.contributor.authorZhang, Wuji-
dc.contributor.authorAllen, Lilith F.-
dc.contributor.authorEarnest, Linda-
dc.contributor.authorMak, Kai Yan-
dc.contributor.authorJuno, Jennifer A.-
dc.contributor.authorWragg, Kathleen-
dc.contributor.authorMordant, Francesca L.-
dc.contributor.authorAmanat, Fatima-
dc.contributor.authorKrammer, Florian-
dc.contributor.authorMifsud, Nicole A.-
dc.contributor.authorDoolan, Denise L.-
dc.contributor.authorFlanagan, Katie L.-
dc.contributor.authorSonda, Sabrina-
dc.contributor.authorKaur, Jasveen-
dc.contributor.authorWakim, Linda M.-
dc.contributor.authorWestall, Glen P.-
dc.contributor.authorJames, Fiona-
dc.contributor.authorMouhtouris, Effie-
dc.contributor.authorGordon, Claire L.-
dc.contributor.authorHolmes, Natasha E.-
dc.contributor.authorSmibert, Olivia C.-
dc.contributor.authorTrubiano, Jason A.-
dc.contributor.authorCheng, Allen C.-
dc.contributor.authorHarcourt, Peter-
dc.contributor.authorClifton, Patrick-
dc.contributor.authorCrawford, Jeremy Chase-
dc.contributor.authorThomas, Paul G.-
dc.contributor.authorWheatley, Adam K.-
dc.contributor.authorKent, Stephen J.-
dc.contributor.authorRossjohn, Jamie-
dc.contributor.authorTorresi, Joseph-
dc.contributor.authorKedzierska, Katherine-
dc.date.accessioned2025-05-19T05:46:32Z-
dc.date.available2025-05-19T05:46:32Z-
dc.date.issued2021-
dc.identifier.citationImmunity, 2021, v. 54, n. 5, p. 1066-1082.e5-
dc.identifier.issn1074-7613-
dc.identifier.urihttp://hdl.handle.net/10722/355899-
dc.description.abstractTo better understand primary and recall T cell responses during coronavirus disease 2019 (COVID-19), it is important to examine unmanipulated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells. By using peptide-human leukocyte antigen (HLA) tetramers for direct ex vivo analysis, we characterized CD8+ T cells specific for SARS-CoV-2 epitopes in COVID-19 patients and unexposed individuals. Unlike CD8+ T cells directed toward subdominant epitopes (B7/N257, A2/S269, and A24/S1,208) CD8+ T cells specific for the immunodominant B7/N105 epitope were detected at high frequencies in pre-pandemic samples and at increased frequencies during acute COVID-19 and convalescence. SARS-CoV-2-specific CD8+ T cells in pre-pandemic samples from children, adults, and elderly individuals predominantly displayed a naive phenotype, indicating a lack of previous cross-reactive exposures. T cell receptor (TCR) analyses revealed diverse TCRαβ repertoires and promiscuous αβ-TCR pairing within B7/N105+CD8+ T cells. Our study demonstrates high naive precursor frequency and TCRαβ diversity within immunodominant B7/N105-specific CD8+ T cells and provides insight into SARS-CoV-2-specific T cell origins and subsequent responses.-
dc.languageeng-
dc.relation.ispartofImmunity-
dc.subjectCOVID-19-
dc.subjectimmunodominant-
dc.subjectSARS-CoV-2-specific CD8+-
dc.subjectT cells-
dc.subjectTCR-
dc.titleCD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.immuni.2021.04.009-
dc.identifier.pmid33951417-
dc.identifier.scopuseid_2-s2.0-85105283794-
dc.identifier.volume54-
dc.identifier.issue5-
dc.identifier.spage1066-
dc.identifier.epage1082.e5-
dc.identifier.eissn1097-4180-
dc.identifier.isiWOS:000652019500020-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats